{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:04:05Z","timestamp":1792019045771,"version":"4.4.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":60,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research Reports"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.lrr.2026.100577","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T08:22:43Z","timestamp":1772526163000},"page":"100577","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Delayed fatal neurotoxicity in post CAR-T cell therapy for multiple myeloma, a case report"],"prefix":"10.1016","volume":"25","author":[{"given":"Hamza","family":"Khoudari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2786-4023","authenticated-orcid":false,"given":"Abdalla","family":"Shoaib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Nashatizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nausheen","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Forat","family":"Lutfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Mushtaq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leyla","family":"Shune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anurag","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Abhyankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"McGuirk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5369-8551","authenticated-orcid":false,"given":"Haitham","family":"Abdelhakim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.lrr.2026.100577_bib0001","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nrclinonc.2011.63","article-title":"Treatment of multiple myeloma","volume":"8","author":"Rajkumar","year":"2011","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.lrr.2026.100577_bib0002","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/s41375-020-0734-z","article-title":"B-cell maturation antigen (BCMA) in multiple myeloma: rationale for targeting and current therapeutic approaches","volume":"34","author":"Shah","year":"2020","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.lrr.2026.100577_bib0003","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.jtct.2024.06.012","article-title":"Timing of toxicities and non-relapse mortality following CAR T therapy in myeloma","volume":"30","author":"Wesson","year":"2024","journal-title":"Transplant. Cell. Ther."},{"issue":"6","key":"10.1016\/j.lrr.2026.100577_bib0004","doi-asserted-by":"crossref","first-page":"e1576","DOI":"10.1002\/wsbm.1576","article-title":"Mechanisms of immune effector cell-associated neurotoxicity syndrome after CAR-T treatment","volume":"14","author":"Gu","year":"2022","journal-title":"WIREs Mech. Dis."},{"issue":"Supplement 1","key":"10.1016\/j.lrr.2026.100577_bib0005","doi-asserted-by":"crossref","first-page":"4758","DOI":"10.1182\/blood-2024-201783","article-title":"Delayed neurotoxicity after CAR-T in multiple myeloma: results from a global IMWG registry","volume":"144","author":"Kumar","year":"2024","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.lrr.2026.100577_bib0006","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1016\/S1470-2045(24)00715-0","article-title":"Non-ICANS neurological complications after CAR T-cell therapies: recommendations from the EBMT Practice Harmonisation and Guidelines Committee","volume":"26","author":"Graham","year":"2025","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.lrr.2026.100577_bib0007","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.577027","article-title":"Cytokines in CAR T cell-associated neurotoxicity","volume":"11","author":"Gust","year":"2020","journal-title":"Front Immunol"},{"issue":"20","key":"10.1016\/j.lrr.2026.100577_bib0008","first-page":"2443","article-title":"How I treat unique and difficult-to-manage cases of CAR T-cell therapy\u2013associated neurotoxicity","volume":"141","author":"Santomasso","year":"2023","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.lrr.2026.100577_bib0009","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1007\/s00415-020-10237-3","article-title":"Neurological updates: neurological complications of CAR-T therapy","volume":"268","author":"Tallantyre","year":"2021","journal-title":"J Neurol"},{"issue":"7","key":"10.1016\/j.lrr.2026.100577_bib0010","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/jnnp-2024-333924","article-title":"Neurotoxic complications of chimeric antigen receptor (CAR) T-cell therapy","volume":"96","author":"Vonberg","year":"2025","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.1016\/j.lrr.2026.100577_bib0011","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41577-021-00547-6","article-title":"Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy","volume":"22","author":"Morris","year":"2022","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.lrr.2026.100577_bib0012","doi-asserted-by":"crossref","first-page":"e1576","DOI":"10.1002\/wsbm.1576","article-title":"Mechanisms of immune effector cell-associated neurotoxicity syndrome after CAR-T treatment","volume":"14","author":"Gu","year":"2022","journal-title":"WIREs Mech Dis"},{"key":"10.1016\/j.lrr.2026.100577_bib0013","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.mcn.2014.01.002","article-title":"Selective regulation of axonal growth from developing hippocampal neurons by tumor necrosis factor superfamily member APRIL","volume":"59","author":"Os\u00f3rio","year":"2014","journal-title":"Mol. Cell. Neurosci."},{"issue":"12","key":"10.1016\/j.lrr.2026.100577_bib0014","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1038\/s41591-021-01564-7","article-title":"Neurocognitive and hypokinetic movement disorder with features of parkinsonism after BCMA-targeting CAR-T cell therapy","volume":"27","author":"Van Oekelen","year":"2021","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.lrr.2026.100577_bib0015","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.tins.2012.09.005","article-title":"The Allen Human Brain Atlas: comprehensive gene expression mapping of the human brain","volume":"35","author":"Shen","year":"2012","journal-title":"Trends Neurosci"},{"issue":"4","key":"10.1016\/j.lrr.2026.100577_bib0016","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1369\/00221554221079579","article-title":"Comprehensive BCMA expression profiling in adult normal Human brain suggests a low risk of on-target neurotoxicity in BCMA-targeting Multiple Myeloma therapy","volume":"70","author":"Marella","year":"2022","journal-title":"J. Histochem. Cytochem."},{"issue":"12","key":"10.1016\/j.lrr.2026.100577_bib0017","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/mdc3.14239","article-title":"Parkinsonism associated with anti-B-cell maturation antigen chimeric antigen receptor T-cell therapy","volume":"11","author":"Schneider","year":"2024","journal-title":"Mov Disord Clin Pr."},{"issue":"26","key":"10.1016\/j.lrr.2026.100577_bib0018","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1056\/NEJMoa1707447","article-title":"Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma","volume":"377","author":"Neelapu","year":"2017","journal-title":"N Engl. J. Med"},{"issue":"4","key":"10.1016\/j.lrr.2026.100577_bib0019","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1182\/bloodadvances.2019000952","article-title":"Comparing CAR T-cell toxicity grading systems: application of the ASTCT grading system and implications for management","volume":"4","author":"Pennisi","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.lrr.2026.100577_bib0020","article-title":"Toxicities of chimeric antigen receptor T cell therapy in multiple myeloma: an overview of experience from clinical trials","volume":"11","author":"Zhou","year":"2020","journal-title":"Pathophysiol. Manag. Strateg., Front Immunol"},{"issue":"2","key":"10.1016\/j.lrr.2026.100577_bib0021","doi-asserted-by":"crossref","first-page":"S202","DOI":"10.1016\/j.jtct.2025.01.313","article-title":"Risk factors for delayed neurotoxicity in patients with relapsed myeloma who received Ciltacabtagene Autoleucel (cilta-cel)","volume":"31","author":"Lim","year":"2025","journal-title":"Transplant. Cell. Ther."},{"issue":"3","key":"10.1016\/j.lrr.2026.100577_bib0022","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41434-018-0019-6","article-title":"Fludarabine and neurotoxicity in engineered T-cell therapy","volume":"25","author":"Lowe","year":"2018","journal-title":"Gene Ther."},{"issue":"1","key":"10.1016\/j.lrr.2026.100577_bib0023","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41522-025-00786-8","article-title":"Gut microbiota shapes cancer immunotherapy responses","volume":"11","author":"Lei","year":"2025","journal-title":"Npj Biofilms Microbiomes"},{"issue":"13","key":"10.1016\/j.lrr.2026.100577_bib0024","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1182\/bloodadvances.2024013809","article-title":"Antibiotic use: impact on the microbiome and cellular therapy outcomes","volume":"9","author":"Darwin","year":"2025","journal-title":"Blood. Adv"},{"issue":"23","key":"10.1016\/j.lrr.2026.100577_bib0025","doi-asserted-by":"crossref","first-page":"5312","DOI":"10.1182\/bloodadvances.2021004896","article-title":"Infectious complications of CAR T-cell therapy across novel antigen targets in the first 30 days","volume":"5","author":"Mikkilineni","year":"2021","journal-title":"Blood Adv"}],"container-title":["Leukemia Research Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048926000178?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048926000178?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T07:10:54Z","timestamp":1785481854000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213048926000178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":25,"alternative-id":["S2213048926000178"],"URL":"https:\/\/doi.org\/10.1016\/j.lrr.2026.100577","relation":{},"ISSN":["2213-0489"],"issn-type":[{"value":"2213-0489","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Delayed fatal neurotoxicity in post CAR-T cell therapy for multiple myeloma, a case report","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lrr.2026.100577","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100577"}}